Matsui Doreen
Department of Paediatrics and Medicine, Children's Hospital, London Health Sciences Centre, Child Health Research Institute, University of Western Ontario, 800 Commissioners Road East, London, ON, N6A 5W9, Canada,
Paediatr Drugs. 2015 Feb;17(1):31-5. doi: 10.1007/s40272-014-0104-2.
Pregnant women with illness require efficacious and safe drug therapy during pregnancy; however, their treatment is often hindered by a lack of information regarding the use of medications during pregnancy. Ethical challenges are encountered in conducting drug trials in pregnant women, who are often excluded from participation due to fear of harm to the fetus. However, as the health of the fetus is ultimately affected by that of the pregnant woman, inclusion of pregnant women in studies of medications that they may require for their own benefit may also benefit the unborn child. The principle of autonomy argues for the pregnant woman being able to make an informed choice to take part in a clinical trial, and the principle of justice dictates that she not be denied the benefits of drug research.
患病的孕妇在孕期需要有效且安全的药物治疗;然而,她们的治疗常常因缺乏孕期用药信息而受阻。在孕妇中进行药物试验会遇到伦理挑战,由于担心对胎儿造成伤害,孕妇常常被排除在试验参与之外。然而,由于胎儿的健康最终会受到孕妇健康状况的影响,让孕妇参与她们自身可能需要的药物研究,对未出生的孩子也可能有益。自主原则主张孕妇能够做出明智的选择来参与临床试验,而公正原则要求不应剥夺她从药物研究中获益的权利。